Ermakova, A.O. (Anna O.)

Search Results

Now showing 1 - 2 of 2
  • Thumbnail Image
    Cortical and striatal reward processing in Parkinson's disease psychosis
    (Frontiers Media, 2017) Fletcher, P.C. (Paul C.); Arrondo, G. (Gonzalo); Justicia, A. (Azucena); Robbins, T.W. (Trevor W.); Barker, R.A. (Roger A.); Ramachandra, P. (Pranathi); Garofalo, S. (Sara); Tudor-Sfetea, C. (Carina); Murray, G.K. (Graham K.); Ermakova, A.O. (Anna O.)
    Psychotic symptoms frequently occur in Parkinson's disease (PD), but their pathophysiology is poorly understood. According to the National Institute of Health RDoc programme, the pathophysiological basis of neuropsychiatric symptoms may be better understood in terms of dysfunction of underlying domains of neurocognition in a trans-diagnostic fashion. Abnormal cortico-striatal reward processing has been proposed as a key domain contributing to the pathogenesis of psychotic symptoms in schizophrenia. This theory has received empirical support in the study of schizophrenia spectrum disorders and preclinical models of psychosis, but has not been tested in the psychosis associated with PD. We, therefore, investigated brain responses associated with reward expectation and prediction error signaling during reinforcement learning in PD-associated psychosis. An instrumental learning task with monetary gains and losses was conducted during an fMRI study in PD patients with (n = 12), or without (n = 17), a history of psychotic symptoms, along with a sample of healthy controls (n = 24). We conducted region of interest analyses in the ventral striatum (VS), ventromedial prefrontal and posterior cingulate cortices, and whole-brain analyses. There was reduced activation in PD patients with a history of psychosis, compared to those without, in the posterior cingulate cortex and the VS during reward anticipation (p < 0.05 small volume corrected). The results suggest that cortical and striatal abnormalities in reward processing, a putative pathophysiological mechanism of psychosis in schizophrenia, may also contribute to the pathogenesis of psychotic symptoms in PD. The finding of posterior cingulate dysfunction is in keeping with prior results highlighting cortical dysfunction in the pathogenesis of PD psychosis.
  • Thumbnail Image
    Altered subcortical emotional salience processing differentiates Parkinson’s patients with and without psychotic symptoms
    (Elsevier, 2020) Bunzeck, N. (N.); Arrondo, G. (Gonzalo); Justicia, A. (Azucena); Robbins, T.W. (Trevor W.); Williams, G. B. (G. B.); Barker, R.A. (Roger A.); Ramachandra, P. (Pranathi); Garofalo, S. (Sara); Tudor-Sfetea, C. (Carina); Knolle, F. (F.); Murray, G.K. (Graham K.); Duezel, E. (E.); Viviani, R. (R.); Blank, H. (H.); Ermakova, A.O. (Anna O.)
    Objective Current research does not provide a clear explanation for why some patients with Parkinson’s Disease (PD) develop psychotic symptoms. The ‘aberrant salience hypothesis’ of psychosis has been influential and proposes that dopaminergic dysregulation leads to inappropriate attribution of salience to irrelevant/non-informative stimuli, facilitating the formation of hallucinations and delusions. The aim of this study is to investigate whether non-motivational salience is altered in PD patients and possibly linked to the development of psychotic symptoms. Methods We investigated salience processing in 14 PD patients with psychotic symptoms, 23 PD patients without psychotic symptoms and 19 healthy controls. All patients were on dopaminergic medication for their PD. We examined emotional salience using a visual oddball fMRI paradigm that has been used to investigate early stages of schizophrenia spectrum psychosis, controlling for resting cerebral blood flow as assessed with arterial spin labelling fMRI. Results We found significant differences between patient groups in brain responses to emotional salience. PD patients with psychotic symptoms had enhanced brain responses in the striatum, dopaminergic midbrain, hippocampus and amygdala compared to patients without psychotic symptoms. PD patients with psychotic symptoms showed significant correlations between the levels of dopaminergic drugs they were taking and BOLD signalling, as well as psychotic symptom scores. Conclusion Our study suggests that enhanced signalling in the striatum, dopaminergic midbrain, the hippocampus and amygdala is associated with the development of psychotic symptoms in PD, in line with that proposed in the ‘aberrant salience hypothesis’ of psychosis in schizophrenia.